<DOC>
	<DOCNO>NCT02106351</DOCNO>
	<brief_summary>The purpose study assess efficacy safety multiple dos Dysport use treatment upper limb spasticity ( altered skeletal muscle performance ) child cerebral palsy ( CP ) .</brief_summary>
	<brief_title>Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Upper limb spasticity due cerebral palsy Body weight 10 kg MAS score 2 affected elbow wrist flexor Fixed myocontracture Previous phenol alcohol injection within 1 year Severe athetoid dystonic movement Previous plan surgery spasticity elbow wrist flexor Neuromuscular disorder Previous Rhizotomy within 6 month Intrathecal baclofen within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>